Search

Strike Bio RNAi Cancer Treatment Patent Application EP3134528A1

The European Patent Office published patent application EP3134528A1 titled 'Multiple Targeted RNAi for the Treatment of Cancers' on April 15, 2026. The applicants are Strike Bio, Inc. and Baylor College of Medicine, both based in the United States. The invention covers RNAi-based therapeutics targeting multiple genes for cancer treatment, with the application designating 34 European member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.